Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influence of Insulin Resistance on HCV Treatment Response
NCT00351871Phase 4Completed
- Sponsor
- Louisiana State University Health Sciences Center
- Start
- Apr 2002
- Primary completion
- Nov 2007
- Modality
- Polymer-based Nanoparticles, Orthosteric Ligands, Cytokines & Interferons
01
Overview
A Phase 4 trial of peginterferon alfa-2b, ribavirin in hepatitis C (HCV), sponsored by Louisiana State University Health Sciences Center. Started Apr 2002; status: completed.
02
Drugs
peginterferon alfa-2bribavirin
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00351871.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00351871.